In Vitro and In Vivo Antihyperglycemic Effects of New Metabiotics from .

The increasing incidence of diabetes has prompted the need for new treatment strategies, including natural products that reduce glycemia values. This work examined the in vitro and in vivo antihyperglycemic effects of new metabiotics derived from extracts. The metabiotics were obtained from 100% , and two other products, CARDIO and GLYCEMIC, from Anoom Laboratories SRL, which contain other microbial species related to .

Extract-A New Modulator of Dysbiotic Microbiota.

The regular administration of antibiotics is a public concern due to the prejudices of large population groups and the high frequency with which antimicrobial products are prescribed. The current study aimed to evaluate the in vitro effect of a new extract from (BEE) on the human microbiota. One of the disadvantages of this extensive use is the disruption of the human microbiota, leading to potential negative health consequences.